Exploring the Future of Biotech Industry with Former FDA Commissioner Scott Gottlieb
As the global biotech industry continues to evolve at a rapid pace, discussions about maintaining competitiveness and innovation are taking center stage. On Post-Hoc Live, we have delved into topics such as the burgeoning biotech sector in China and the challenges it poses for the US market. Tomorrow, we are excited to have former FDA Commissioner Scott Gottlieb join us to share his insights on what the US needs to do to stay ahead in this dynamic landscape.
In a recent opinion piece, Gottlieb emphasized the importance of adapting clinical trial practices and regulatory frameworks to leverage America’s technological advantages. As a seasoned venture investor and corporate board member, he brings a wealth of experience and knowledge to the table.
You can tune in to our live session with Scott Gottlieb tomorrow at 12:30 p.m. ET. Whether you prefer to watch on our YouTube livestream or add the event to your calendar, there are plenty of ways to engage with this important discussion.
If you’re interested in learning more about the intersection of biotech and global competition, I recommend checking out our previous episodes featuring industry leaders such as Curie.Bio CEO Zach Weinberg and Jefferies head of Asia healthcare research Cui Cui.
At Post-Hoc Live, we are committed to exploring this vital topic in depth. Feel free to participate in the conversation during our live sessions by asking questions in the chat or sharing your ideas for future guests via email. We look forward to seeing you there!
—Drew
